People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Other, Other Health Care, Healthtech, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sight Sciences, Inc. | — | Biotechnology | Series B | $111.3M | $778.7M | 2011 |
| Potrero Medical, Inc. | — | Biotechnology | Series B | $76.2M | $9.9M | 2016 |
| Podimetrics, Inc. | — | Other | Series C | $55.3M | $579.2M | 2017 |
| Channel Medsystems, Inc. | — | Other Health Care | Series B | $54.7M | $35.8M | 2013 |
| Rivermark Medical, Inc. | — | Healthtech | Series B | $35.9M | $188.7M | 2021 |
| Spirair, Inc. | — | Other Health Care | Series B | $24.7M | $116.5M | 2025 |
| BRIUS Technologies, Inc. | — | Software / Tech | Series B | $21.2M | $110.0M | 2025 |
| Artelon, Inc. | — | Biotechnology | Series B | $20.0M | $230.7M | 2023 |
| Anterios Inc | — | Biotechnology | Series A | $17.2M | $171.5M | 2009 |
| Emkinetics Inc | — | Other | Series A | $14.8M | $3.8M | 2010 |
| Lhotse Medical, Inc. | — | Healthtech | Seed | $3.7M | $4.8M | 2023 |
| Esculon, Inc. | — | Biotechnology | Seed | $2.9M | $129.9M | 2017 |
| Cure Dm Inc | — | Other Health Care | Seed | $2.1M | $52.0M | 2009 |
| LiveProcess CORP | — | Other Health Care | Seed | $1.6M | $40.1M | 2012 |
Carter Meyer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Carter Meyer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Burnett | 3 | 11 |
| Andrew ` Offer | 3 | 5 |
| Josh Baltzell | 2 | 7 |
| Alan Chesler | 2 | 5 |
| Kate Garrett | 2 | 3 |
| Anand Doraiswamy | 2 | 3 |
| Gary Burbach | 2 | 3 |
| David Greenberg | 1 | 13 |
| Kirk Nielsen | 1 | 13 |
| Frederic Moll | 1 | 10 |
| Amir Abolfathi | 1 | 8 |
| Frederic H. Moll | 1 | 8 |
| Alexandra Cantley | 1 | 8 |
| Aaron Sandoski | 1 | 7 |
| Geoffrey Smith | 1 | 5 |
| Christopher Kaster | 1 | 5 |
| MARK COHEN | 1 | 5 |
| David Amerson | 1 | 5 |
| Maurice Ferre | 1 | 5 |
| Paul Badawi | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.